.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Merck
Teva
AstraZeneca
Boehringer Ingelheim
Colorcon
Covington
Healthtrust
Daiichi Sankyo
Medtronic

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204418

« Back to Dashboard
NDA 204418 describes FOLIC ACID, which is a drug marketed by Hikma Pharms, Ivax Sub Teva Pharms, Fresenius Kabi Usa, Valeant Pharm Intl, Jubilant Cadista, Nexgen Pharma Inc, Lannett, Nuvo Pharm Inc, Amneal Pharm, Mk Labs, Usl Pharma, Vangard, Tablicaps, Invagen Pharms, Lilly, Cadila Pharms Ltd, Watson Labs, Aiping Pharm Inc, Pioneer Pharms, Everylife, Vintage, Pharmeral, Contract Pharmacal, Ben Venue, Sandoz, Barr, Sun Pharm Inds, Purepac Pharm, Impax Labs, Whiteworth Town Plsn, Leading Pharma Llc, Vintage Pharms, Halsey, and UDL, and is included in thirty-six NDAs. It is available from thirty-eight suppliers. Additional details are available on the FOLIC ACID profile page.

The generic ingredient in FOLIC ACID is folic acid. There are nine drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the folic acid profile page.

Summary for NDA: 204418

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 204418

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FOLIC ACID
folic acid
TABLET;ORAL 204418 ANDA Marlex Pharmaceuticals Inc 10135-182 10135-182-01 100 TABLET in 1 BOTTLE, PLASTIC (10135-182-01)
FOLIC ACID
folic acid
TABLET;ORAL 204418 ANDA Marlex Pharmaceuticals Inc 10135-182 10135-182-10 1000 TABLET in 1 BOTTLE (10135-182-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Jul 28, 2015TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Cerilliant
Medtronic
Merck
McKinsey
QuintilesIMS
Novartis
Teva
Express Scripts
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot